Nachman Norwood & Parrott’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$3.28M Sell
14,283
-22
-0.2% -$4.42K 0.33% 63
2021
Q1
$2.67M Sell
14,305
-19
-0.1% -$3.72K 0.29% 73
2020
Q4
$2.42M Buy
14,324
+64
+0.4% +$9.56K 0.28% 73
2020
Q3
$2.11M Sell
14,260
-268
-2% -$41.5K 0.28% 74
2020
Q2
$2.38M Hold
14,528
0.39% 62
2020
Q1
$2.02M Sell
14,528
-360
-2% -$49.5K 0.41% 56
2019
Q4
$1.96M Buy
14,888
+600
+4% +$69.5K 0.32% 67
2019
Q3
$1.6M Sell
14,288
-141
-1% -$15.7K 0.28% 73
2019
Q2
$1.6M Sell
14,429
-448
-3% -$52.8K 0.29% 72
2019
Q1
$1.93M Buy
14,877
+119
+0.8% +$14.5K 0.36% 69
2018
Q4
$1.71M Buy
+14,758
New +$1.65M 0.36% 68

Other funds holding LLY

Nachman Norwood & Parrott's LLY Position: Q2 2021 in Review

Nachman Norwood & Parrott reduced its Eli Lilly (LLY) stake by 0.15% in Q2 2021, selling an estimated $4.42K and leaving 14,283 shares worth $3.28M. The position accounts for 0.33% of the portfolio, ranked #63.

Nachman Norwood & Parrott first reported a position in LLY in Q4 2018 and has held it in 11 quarters since. 2,022 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Nachman Norwood & Parrott held 14,283 shares of Eli Lilly worth $3.28M as of Q2 2021.
  • Nachman Norwood & Parrott sold 22 Eli Lilly shares in Q2 2021, an estimated $4.42K.
  • Eli Lilly made up 0.33% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #63 holding.
  • Nachman Norwood & Parrott first reported a position in Eli Lilly in Q4 2018 and has held it in 11 quarters since.
  • 2,022 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.